BOEHRINGER MANNHEIM
Boehringer Mannheim is a Germany based maker of drugs and diagnostic products. The company focuses primarily on the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded in 1859 by Albert Boehringer.
BOEHRINGER MANNHEIM
Industry:
Biotechnology Health Care Health Diagnostics Medical Pharmaceutical
Founded:
1859-01-01
Address:
Mannheim, Baden-Wurttemberg, Germany
Country:
Germany
Total Employee:
10001+
Status:
Active
Contact:
(496)217-591
Similar Organizations
Avacta Animal Health
Avacta Animal Health is an veterinary laboratory service provider and diagnostic tester to surgeons, laboratories on animal allergies.
HT médica
HT médica is a provider of radiology consultation and diagnostic imaging solutions.
Hta Consulting
HTA Consulting specializes in health technology assessment for drugs, medical devices and diagnostic methods.
Jaber Ibn Hayyan Pharmaceutical
Jaber Ibn Hayyan Pharmaceutical manufactures drugs like anti-biotic, non-antibiotic , topical, oral and others.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Panodyne
For over 15 years, Panodyne has been the first line of defence against harmful bacteria.
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
Transition Bio
Transition Bio provides condensate technology for drug discovery and diagnostics.
VitrOmics Healthcare Holding BV
VitrOmics Healthcare Holding BV is focusing on the development of new diagnostic products.
Current Employees Featured
Albert Boehringer Founder @ Boehringer Mannheim
Founder
Founder
More informations about "Boehringer Mannheim"
Boehringer Mannheim – Wikipedia
C. F. Boehringer & Söhne GmbH Mannheim (als Marke Boehringer Mannheim) [4] entwickelte sich ab 1960 und unter der Führung von Curt Engelhorn zu einem internationalen Konzern mit …See details»
About Us - Roche Diagnostics USA
Our North American headquarters for Roche Diagnostics Corporation is located in Indianapolis, IN. We have been part of the Indianapolis community since 1964 when Bio-Dynamics was …See details»
Brand Hub | Boehringer Ingelheim – Life forward
Head in to experience our brand experience, identity and design with guidelines, templates and asset libraries.See details»
Geschichte von Roche in Mannheim: We started here
Schnell wurde klar, dass die Kapazitäten in der Stuttgarter Altstadt nicht ausreichen würden, zumal man abhängig von der Wasserversorgung durch die Brunnen war. Deswegen zog das …See details»
Who we are - Boehringer Ingelheim
Apr 2, 2025 Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim.See details»
C.H. Boehringer Sohn -- Company History
C.H. Boehringer Sohn is the holding company for Boehringer Ingelheim GmbH), which is among the top 20 international, research-based pharmaceuticals manufacturers. The company offers prescription drugs for diseases of the …See details»
Hoffman La Roche and Boehringer Mannheim – Mission …
THE EXECUTIVE Management Programme (EMP) reviewed here was a development programme for managers in the Boehringer Mannheim (BM) organization. The overall idea for …See details»
Organization | Boehringer-Mannheim
Boehringer-Mannheim Report issue For profit Founded: Stuttgart Germany (1817) Status: Acquired by Roche (1997) Organization Overview First Clinical Trial 1999 NCT00002385 First …See details»
Boehringer Mannheim's Organization - Nature Biotechnology
Authors and Affiliations Product Manager, Boehringer Mannheim Biochemicals Indianapolis, IN, 46250 Kristen E. KinkadeSee details»
Boehringer Mannheim - Updates, News, Events, Signals & Triggers
Boehringer Mannheim may be growing as evidenced by its acquisition of Bio-Dynamics in 1974, which suggests a strategic expansion of its operations. The company's implementation of its …See details»
Roche Acquires Boehringer Mannheim For $11 Billion
May 28, 1997 Corange sold 15.8 percent of DePuy in a public offering last year. With Roche as the new majority shareholder, DePuy will continue to operate as an independent organization. …See details»
About Us | Boehringer Ingelheim CA
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organization, the …See details»
About us - Boehringer Ingelheim
Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision and the organisation.See details»
Roche-Mannheim: Cornering the diagnosis-led healthcare market
Boehringer Mannheim Lab Diagnostics is the world leader in clinical chemistry, and a moderate player in immunoassays, a good synergistic fit with Roche and its PCR tech nology, according …See details»
The Fall of German Biotech - Kellogg Insight
Jan 1, 2011 The extent to which companies internalized these concerns was related to the diversification of corporate elites and the companies as a whole, Weber found. Boehringer …See details»
A history of... Boehringer Ingelheim - pharmaphorum
4 days ago Boehringer Ingelheim Pharmaceuticals, Inc. was founded in Connecticut, USA, in 1971 and expanded to become the company’s North American research centre.See details»
勃林格殷格翰_百度百科
勃林格殷格翰(Boehringer-Ingelheim)是一家致力于人类生物制药化学和动物健康产品的医药公司，也是世界上最大的私有制药企业。由勃林格家族阿尔伯特·勃林格（Albert Boehringer） …See details»
History - Boehringer Ingelheim
We started writing our part of history some 140 years ago, with just 28 people and our founder Albert Boehringer (1861-1939). Since then, Boehringer Ingelheim has grown from a humble …See details»
Company History | Corporate Profile | Boehringer Ingelheim US
We started writing our part of history some 140 years ago, with just 28 people and our founder Albert Boehringer (1861-1939). Since then Boehringer Ingelheim has grown from a humble …See details»
Zongertinib durable clinically meaningful results with NSCLC ...
1 day ago Boehringer Ingelheim reported new and updated data from the Beamion LUNG-1 trial evaluating zongertinib in previously treated patients with HER2 (ERBB2)-mutant advanced …See details»